Andover Medical Announces Dr. Peter J. Bregman as Chair of the Podiatric Advisory Board.

ANDOVER, Mass. -- Andover Medical, Inc. (AMI), (OTCBB:ADOV.OB) is pleased to announce that Dr. Peter J. Bregman will chair its newly formed Podiatry Advisory Board. Dr. Bregman has been in private practice for 10 years and serves on the board of the American Association of Lower Extremity Peripheral Nerve Surgeons. His special interests include Peripheral Neuropathy and Pediatric foot problems. He is active in teaching, lecturing, and writing for scientific journals. His credentials include a Doctor of Podiatric Medicine from the Temple School of Podiatric Medicine (1994); Chief Resident Cambridge Hospital; Tufts University Achievement of Excellence (2002); and Cambridge Residency Program Attending Physician of the year (2003).

With one in six AmericansCo many diabeticCo experiencing foot problems in their lives, the need for podiatric specialties is on the rise. The occurrence of foot disease, the most common complication of diabetes leading to hospitalization, has risen drastically as the number of diabetics has grown significantly in recent years. With the formation of the Podiatric Advisory Board, AMI will continue to advocate for practicing podiatrists as well as podiatric research and development.

About Andover Medical, Inc.

Andover Medical, Inc. (AMI) is building a single source provider of orthopedic, podiatric and urological durable medical equipment and incontinence treatment solutions. The Company intends to establish a nationwide subsidiary network and plans to offer physicians the largest selection of competitively priced brand-name durable medical equipment, and urodynamic diagnostic and treatment products. For more information, please call [phone] or visit www.andovermedical.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These forward looking statements include plans to offer physicians the largest selection of competitively priced brand-name durable medical equipment, and urodynamic diagnostic and treatment products. All forward-looking statements speak only as of the date of this press release. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, achievements or transactions of AMI and its affiliates to be materially different from any future results, performance, achievements or transactions expressed or implied by such forward-looking statements. Such risks, uncertainties and other factors which, could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.